Skip to Main Content

Author Details

Mukesh Bansal
2005
49
27
PMIDPaper TitleJournal TitlePublished Year
37560472Enrichment analysis of phenotypic data for drug repurposing in rare diseases.2023
34433651TOP2B Enzymatic Activity on Promoters and Introns Modulates Multiple Oncogenes in Human Gliomas.Clin Cancer Res2021
33309017Computational Analysis of Multidimensional Behavioral Alterations After Chronic Social Defeat Stress.Biological Psychiatry2021
33354662<i>N</i>-quinoline-benzenesulfonamide derivatives exert potent anti-lymphoma effect by targeting NF-κB.iScience2020
32528131Ribosomal protein S11 influences glioma response to TOP2 poisons.Oncogene2020
30824677Correction: Novel Hybrid Phenotype Revealed in Small Cell Lung Cancer by a Transcription Factor Network Model That Can Explain Tumor Heterogeneity.Cancer Res2019
30615629Elucidating synergistic dependencies in lung adenocarcinoma by proteome-wide signaling-network analysis.PLoS One2019
30658994Experimental microdissection enables functional harmonisation of pancreatic cancer subtypes.Gut2019
29684207The number of titrated microRNA species dictates ceRNA regulation.Nucleic Acids Res2018
30188892FGF-induced Pea3 transcription factors program the genetic landscape for cell fate determination.PLoS Genetics2018
28174276Synergistic antileukemic therapies in <i>NOTCH1</i>-induced T-ALL.Proc Natl Acad Sci U S A2017
28558729High-throughput validation of ceRNA regulatory networks.BMC Genomics2017
28331001Quantitative Tyrosine Phosphoproteomics of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor-treated Lung Adenocarcinoma Cells Reveals Potential Novel Biomarkers of Therapeutic Response.Mol Cell Proteomics2017
29028795Alx4 relays sequential FGF signaling to induce lacrimal gland morphogenesis.PLoS Genet2017
28299802Bone morphogenetic protein and Notch signalling crosstalk in poor-prognosis, mesenchymal-subtype colorectal cancer.Journal of Pathology2017
27932399Novel Hybrid Phenotype Revealed in Small Cell Lung Cancer by a Transcription Factor Network Model That Can Explain Tumor Heterogeneity.Cancer Res2017
27632225Correction: Inferring Protein Modulation from Gene Expression Data Using Conditional Mutual Information.PLoS One2016
26875846Functional Effectiveness of Inpatient Rehabilitation After Heart Transplantation.PM and R2016
26735018An ID2-dependent mechanism for VHL inactivation in cancer.Nature2016
26589882Elucidation and Pharmacological Targeting of Novel Molecular Drivers of Follicular Lymphoma Progression.Cancer Res2016
26366712Disruption of KMT2D perturbs germinal center B cell development and promotes lymphomagenesis.Nat Med2015
25419707Aberrant epithelial GREM1 expression initiates colonic tumorigenesis from cells outside the stem cell niche.Nat Med2015
25336442Interrogation of a context-specific transcription factor network identifies novel regulators of pluripotency.Stem Cells2015
26186195Elucidating Compound Mechanism of Action by Network Perturbation Analysis.Cell2015
26040656Direct ChIP-Seq significance analysis improves target prediction.BMC Genomics2015
26110827ABC transporters and the proteasome complex are implicated in susceptibility to Stevens-Johnson syndrome and toxic epidermal necrolysis across multiple drugs.PLoS One2015
26334955A reverse-engineering approach to dissect post-translational modulators of transcription factor's activity from transcriptional data.BMC Bioinformatics2015
24880487A community effort to assess and improve drug sensitivity prediction algorithms.Nat Biotechnol2014
25419740A community computational challenge to predict the activity of pairs of compounds.Nat Biotechnol2014
25314274Inferring protein modulation from gene expression data using conditional mutual information.PLoS One2014
24390738The transcriptional regulatory network of proneural glioma determines the genetic alterations selected during tumor progression.Cancer Res2014
24440720ZFHX4 interacts with the NuRD core member CHD4 and regulates the glioblastoma tumor-initiating cell state.Cell Rep2014
24637229Convection-enhanced delivery of etoposide is effective against murine proneural glioblastoma.Neuro Oncol2014
23974956MEF2B mutations lead to deregulated expression of the oncogene BCL6 in diffuse large B cell lymphoma.Nat Immunol2013
24027026A molecular signature predictive of indolent prostate cancer.Sci Transl Med2013
21938624Genome-wide dissection of posttranscriptional and posttranslational interactions.Methods Mol Biol2012
22366949Reverse engineering of TLX oncogenic transcriptional networks identifies RUNX1 as tumor suppressor in T-ALL.Nat Med2012
22000015An extensive microRNA-mediated network of RNA-RNA interactions regulates established oncogenic pathways in glioblastoma.Cell2011
21314454Mass conservation and inference of metabolic networks from high-throughput mass spectrometry data.J Comput Biol2011
19327819A yeast synthetic network for in vivo assessment of reverse-engineering and modeling approaches.Cell2009
18441228Direct targets of the TRP63 transcription factor revealed by a combination of gene expression profiling and reverse engineering.Genome Research2008
17299415How to infer gene networks from expression profiles.Molecular Systems Biology2007
17907680Inference of gene networks from temporal gene expression profiles.IET Systems Biology2007
17591175Linear matrix inequalities approach to reconstruction of biological networks.IET Systems Biology2007
17118162Computational framework for the prediction of transcription factor binding sites by multiple data integration.BMC Neurosci2006
16418235Inference of gene regulatory networks and compound mode of action from time course gene expression profiles.Bioinformatics2006
17281300Discovering drug mode of action using reverse-engineered gene networks.Annual International Conference of the IEEE Engineering in Medicine and Biology - Proceedings2005
17281529Identification of quadratic nonlinear models oriented to genetic network analysis.Annual International Conference of the IEEE Engineering in Medicine and Biology - Proceedings2005
16141072The transcriptional landscape of the mammalian genome.Science2005
  • 1 - 49 of 49

Recommended Authors

Collaborators

Columbia University
Co-authored papers 26
Co-authored papers 11
Co-authored papers 8
Baylor College of Medicine
Co-authored papers 6
Co-authored papers 5
Northwestern University
Co-authored papers 4
Columbia University
Co-authored papers 3
Children's Hospital of Philadelphia
Co-authored papers 3
Columbia University
Co-authored papers 3
Herbert Irving Cancer Research Center, Columbia University Medical Center
Co-authored papers 3
Oregon Health Sciences University
Co-authored papers 2
Institute for Cancer Genetics, Columbia University
Co-authored papers 2
Institute for Cancer Genetics, Columbia University
Co-authored papers 2
The Scripps Research Institute
Co-authored papers 2
Institute of Computational Biomedicine, Heidelberg University
Co-authored papers 2
Icahn School of Medicine at Mount Sinai
Co-authored papers 2
Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Co-authored papers 2
Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center
Co-authored papers 2
University of Colorado Anschutz Medical Campus
Co-authored papers 2
IBM T.J. Watson Research Center
Co-authored papers 2
International Centre for Genetic Engineering and Biotechnology
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Istituto Italiano di Tecnologia
Co-authored papers 1
Center for Omics Sciences, IRCCS San Raffaele Scientific Institute
Co-authored papers 1
Institute of Genetics and Cancer, University of Edinburgh
Co-authored papers 1
Japan Tobacco Inc.
Co-authored papers 1
The University of Texas Southwestern Medical Center
Co-authored papers 1
University of Texas Southwestern Medical Center at Dallas
Co-authored papers 1